3.68
Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten
When is the best time to buy Relay Therapeutics Inc. stockFree Consultation - jammulinksnews.com
Will Relay Therapeutics Inc. stock benefit from AI tech trendsFree Stock Index Interpretation - jammulinksnews.com
What analysts say about Relay Therapeutics Inc. stockHigh-margin investment plays - Autocar Professional
What drives Relay Therapeutics Inc. stock priceTriple-digit profit margins - Autocar Professional
Is Relay Therapeutics Inc. a good long term investmentFree Risk Assessment Services - Autocar Professional
Relay Therapeutics Inc. Stock Analysis and ForecastExceptional earning trajectories - jammulinksnews.com
Why Relay Therapeutics Inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser
what makes relay therapeutics inc. stock price move sharplyTargeted 200 Percent Gain - Newser
Is Relay Therapeutics Inc. stock overhyped or has real potentialLong Term Secure Gain Stocks - Newser
Is Relay Therapeutics Inc. stock a good hedge against inflationFree Stock Market Insider Analysis - Newser
RLAY’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? - The Globe and Mail
How Relay Therapeutics Inc. stock performs during market volatilityFree Real-Time Trading Opportunities - Newser
What makes Relay Therapeutics Inc. stock price move sharplyTrade Ready Signal - Newser
DekaBank Deutsche Girozentrale Raises Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Have Relay Therapeutics Insiders Been Selling Stock? - simplywall.st
Wealth Enhancement Advisory Services LLC Makes New $41,000 Investment in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
AI drug discovery platform Market May See a Big Move | Major Giants - openPR.com
Relay Therapeutics CEO Patel sells $219k in shares By Investing.com - Investing.com Canada
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Can RXRX's AI-Based Approach Revolutionize the Drug Discovery Process? - TradingView
BofA Reiterates a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PT - Yahoo Finance
13 Best Long-Term Penny Stocks to Buy According to Analysts - Insider Monkey
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology - PR Newswire
Unraveling Relay Therapeutics' 9.8% Spike: A Closer Look at the Anomaly - AInvest
In the Green: Relay Therapeutics Inc (RLAY) Closes at 3.06, Up/Down -6.42 from Previous Day - DWinneX
Relay Therapeutics’ SWOT analysis: AI-driven drug discovery stock faces pivotal phase - Investing.com India
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by California State Teachers Retirement System - Defense World
# Relay Therapeutics appoints Bicara CEO to board ahead of breast cancer trial - Investing.com India
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors | RLAY Stock News - GuruFocus
Relay Therapeutics Appoints Claire Mazumdar to Board of Directors - citybiz
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):